Neoleukin Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Neoleukin Therapeutics, Inc.

Welcome to our dedicated page for Neoleukin Therapeutics, Inc. (Nasdaq: NLTX) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Neoleukin Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Neoleukin Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for NLTX
TickerTime & DateFilingLink
NLTX09:08:02 PM, 08/17/2023
BAKER BROS. ADVISORS LP purchased 2285342 shares of Neoleukin Therapeutics, Inc. (NLTX) for ~$1461444
Filing
NLTX08:06:55 PM, 08/14/2023
Smith Sean Michael(Interim CFO, Prin Acct Off) sold 1323 shares of Neoleukin Therapeutics, Inc. (NLTX) for ~$820
Filing
NLTX12:51:03 AM, 04/05/2023
Patel Priti sold 3769 shares of Neoleukin Therapeutics, Inc. (NLTX) for ~$2600
Filing
NLTX09:33:55 PM, 02/03/2023
Smith Sean Michael(Principal Accounting Officer) sold 3316 shares of Neoleukin Therapeutics, Inc. (NLTX) for ~$1989
Filing
NLTX09:32:55 PM, 02/03/2023
Patel Priti(Chief Medical Officer) sold 14380 shares of Neoleukin Therapeutics, Inc. (NLTX) for ~$8628
Filing